Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Antares Pharma (ATRS)

Antares Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATRS
DateTimeSourceHeadlineSymbolCompany
26/05/202222:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
26/05/202222:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:46Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
24/05/202221:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
24/05/202214:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ATRSAntares Pharma Inc
24/05/202211:11Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ATRSAntares Pharma Inc
13/05/202221:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
12/05/202213:00PR Newswire (US)Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares PharmaNASDAQ:ATRSAntares Pharma Inc
12/05/202212:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
12/05/202212:02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ATRSAntares Pharma Inc
10/05/202222:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
10/05/202221:42Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
06/05/202217:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ATRSAntares Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ATRS

Your Recent History